Immunotherapy Clinical Trial Reveals Brain Tumor Shrinkage, Continues with Phase 3 Study – PR Newswire (press release)
|
Immunotherapy Clinical Trial Reveals Brain Tumor Shrinkage, Continues with Phase 3 Study
PR Newswire (press release) SUMMIT, N.J., April 25, 2018 /PRNewswire/ — Following successful Phase 1 clinical trials, the Toca regimen – a new immunotherapy for patients with recurrent brain cancer – has advanced to a Phase 3 study, which is currently underway. The trial is … |
